‘Prevalence, experience and awareness of substandard and falsified medicines among the public and healthcare professionals in Jordan’

Awareness of SF medicines in Jordan is critically low among both the public and healthcare professionals. The absence of formal reporting systems and economic constraints exacerbates the issue, increasing the risk of exposure to SF medicines. Urgent interventions, including nationwide education campaigns, the establishment of structured reporting mechanisms and policies addressing financial barriers, are essential to mitigating the impact of SF medicines on public health.